If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosalt Regulatory News (SALT)

Share Price Information for Microsalt (SALT)

Share Price is delayed by 15 minutes
Get Live Data
33.50    -0.50 (-1.47%)
Bid:
33.00
Ask:
34.00
Spread: 1.00 (3.03%)
Market Cap: £18.81m
SALT Live PriceLast checked at - London Stock Exchange

Intraday Microsalt Share Chart

Grant of Options, PDMR Dealing & TVR

1 Jul 2026 07:00

RNS Number : 4878K
MicroSalt PLC
01 July 2026
 

1 July 2026

MicroSalt Plc

("MicroSalt" or the "Company")

Grant of Options, PDMR Dealing and Total Voting Rights

MicroSalt plc (AIM:SALT), a leading manufacturer of full-flavour natural salt with approximately 50% less sodium, announces that 206,268 ordinary shares of £0.001625 each in the capital of the Company ("Ordinary Shares") ("Option Shares") have been allotted to two shareholders to satisfy the exercise of options over Ordinary Shares.

Options over an aggregate of 228,000 Ordinary Shares were exercised on a cashless basis under an option agreement entered into in September 2023. Due to the cashless basis of the exercise a total of 149,984 Option Shares were allotted and issued. Pursuant to the terms of the option agreement, the exercise price of each Option Share was US$0.25.

In addition, a PDMR has exercised options over 56,284 shares for nil consideration.

Total Voting Rights

The Company has identified certain historical errors with Ordinary Shares having been admitted to trading that had not been allotted or issued to shareholders. The discrepancy relates to the exercise of warrants in 2024, and resulted in 232,519 Ordinary Shares being admitted to trading without having been allotted or issued. As a result, the Company will be cancelling the admission of those 232,519 Ordinary Shares. It is anticipated this cancellation will take effect from 2 July 2026.

Additionally, application has been made to the London Stock Exchange for admission of the Option Shares to trading on AIM ("Admission"). It is expected that Admission will become effective on or around 2 July 2026.

Following the cancellation of Ordinary Shares outlined above, and the issue of the Option Shares, which on Admission will rank pari passu with the existing Ordinary Shares, the total number of Ordinary Shares in issue with voting rights in the Company will be 56,117,642. There are no Ordinary Shares held in treasury.

The above figure of 56,117,642 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information, please contact:

MicroSalt plc

info@microsaltinc.com

Rick Guiney (CEO)

Zeus (Nominated Adviser and Broker)

+44 (0)20 3829 5000

David Foreman / James Edis (Investment Banking)

Dom King (Corporate Broking) / Rupert Woolfenden (Sales)

Gracechurch Group (Financial PR)

+44 (0)20 4582 3500

Heather Armstrong, Alexis Gore, Rebecca Scott

 

Further information on the Company can be found on its website at: www.microsaltinc.co

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

Further details are set out in the below notification, made in accordance with the requirements of the UK Market Abuse Regulation

 

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Javier Contreras

2

Reason for notification

a.

Position/Status

COO

 

b.

Initial notification/

Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

MicroSalt plc

b.

LEI

213800L7WRHP8CCEEQ48

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary Shares of £0.001625 each

 

ISIN: GB00BQB6FF85

b.

Nature of the transaction

Exercise of Options

c.

Price(s) and volume(s)

 

Price(s)

Volume(s)

nil

56,284

d.

Aggregated information

 

As above

e.

Date of the transactions

24 June 2026

f.

Place of the transaction

London Stock Exchange

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAAKEDLDKEAA
12
Date   Source Headline
1st Jul 20267:01 amRNSResult of AGM
1st Jul 20267:00 amRNSGrant of Options, PDMR Dealing & TVR
5th Jun 20267:00 amRNSNotice of AGM
28th May 20267:07 amRNSFinal Results
28th Apr 20267:00 amRNS-RMicroSalt Launches MicroSalt Fibre
5th Mar 20267:00 amRNS-RNew UK customer
2nd Mar 20267:00 amRNS-RMicroSalt Reaches One Billion Servings Milestone
13th Feb 20267:00 amRNSGrant of options and PDMR dealings
27th Jan 20267:25 amRNSSigned Joint Development Agreement
12th Jan 20267:00 amRNSTrading Update
15th Dec 20252:17 pmRNSAdmission, Director Dealings and TVR
12th Dec 20252:30 pmRNSResult of Retail Offer
9th Dec 20254:35 pmRNSLaunch of Retail Offer
9th Dec 20252:40 pmRNSSubscription to raise £1.5 million
21st Nov 20253:38 pmRNSExercise of Stock Options and Total Voting Rights
14th Nov 20257:00 amRNSTrading Update
12th Nov 20257:00 amRNSNew Strategic Relationship with Daiya Foods
30th Sep 20257:00 amRNSUnaudited Half-yearly Report
1st Sep 20257:00 amRNSBoard changes
18th Aug 20257:00 amRNSH1 2025 Trading Update
11th Aug 20257:00 amRNSMissed related party transaction
6th Aug 20257:38 amRNSRelated Party Transaction
27th Jun 20253:48 pmRNSResult of AGM
6th Jun 202512:30 pmRNSHolding(s) in Company
2nd Jun 20257:01 amRNSNotice of Investor Presentation 9th June 2025
2nd Jun 20257:00 amRNSFinal Results Year Ended 31 December Notice of AGM
24th Apr 20257:00 amRNSQ1 2025 Business Update
24th Mar 20257:00 amRNS-RIFE London Innovation in Nutritious Foods
19th Mar 20257:00 amRNS-RFast Award 2025
25th Feb 20257:00 amRNS-RTechnology of the Year 2025 Award
14th Feb 20251:22 pmRNSNotification of Major Holdings
14th Feb 20251:06 pmRNSNotification of Major Holdings
7th Feb 20257:00 amRNSFurther Re Fundraising
5th Feb 20257:00 amRNSExercise of Stock Options and Total Voting Rights
3rd Feb 20257:00 amRNSOversubscribed Fundraising of £2.3Million
16th Jan 20257:00 amRNS-RFDA Nutrition information on packaged foods
6th Jan 20254:51 pmRNSResults of General Meeting
10th Dec 20247:00 amRNSShareholder Circular and Notice of General Meeting
30th Oct 20247:00 amRNSNew and Follow-on B2B Customer Orders
18th Oct 20247:00 amRNSResponse to Share Price Movement
27th Sep 20247:00 amRNSMaiden Interim Results
16th Sep 20247:00 amRNSMultiple Placements of Products and B2B Progress
2nd Aug 20243:02 pmRNSNotification of Major Holdings
30th Jul 20247:00 amRNSExercise of Warrants and Total Voting Rights
16th Jul 20247:00 amRNSExercise Warrants PDMR Dealing Total Voting Rights
11th Jul 20247:00 amRNSExercise of Warrants and Total Voting Rights
2nd Jul 20243:31 pmRNSExercise of Warrants and Total Voting Rights
21st Jun 20243:17 pmRNSResult of AGM
17th Jun 202411:22 amRNSExercise Warrants PDMR Dealing Total Voting Rights
11th Jun 20247:00 amRNSExercise Warrants Options and Total Voting Rights
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.